These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Retesting of women who are negative for a Lerner-Ellis J; Sopik V; Wong A; Lázaro C; Narod SA; Charames GS J Med Genet; 2020 Jun; 57(6):380-384. PubMed ID: 31784482 [TBL] [Abstract][Full Text] [Related]
44. Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. Wolf I; Laitman Y; Rubinek T; Abramovitz L; Novikov I; Beeri R; Kuro-O M; Koeffler HP; Catane R; Freedman LS; Levy-Lahad E; Karlan BY; Friedman E; Kaufman B Oncogene; 2010 Jan; 29(1):26-33. PubMed ID: 19802015 [TBL] [Abstract][Full Text] [Related]
45. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk. Ricks-Santi LJ; Sucheston LE; Yang Y; Freudenheim JL; Isaacs CJ; Schwartz MD; Dumitrescu RG; Marian C; Nie J; Vito D; Edge SB; Shields PG BMC Cancer; 2011 Jun; 11():278. PubMed ID: 21708019 [TBL] [Abstract][Full Text] [Related]
46. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer]. Liu WL; Zhao JZ; Wang ZZ; Dong B; Hou YY; Wu XX; Guo YJ Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):403-410. PubMed ID: 28647964 [No Abstract] [Full Text] [Related]
49. Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer. Guénard F; Labrie Y; Ouellette G; Beauparlant CJ; Durocher F; J Hum Genet; 2009 Mar; 54(3):152-61. PubMed ID: 19197335 [TBL] [Abstract][Full Text] [Related]
50. Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing. Byers H; Wallis Y; van Veen EM; Lalloo F; Reay K; Smith P; Wallace AJ; Bowers N; Newman WG; Evans DG Eur J Hum Genet; 2016 Nov; 24(11):1591-1597. PubMed ID: 27273131 [TBL] [Abstract][Full Text] [Related]
51. Functional characterization of BRCA1 and BRCA2: clues from their interacting proteins. Sharan SK; Bradley A J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):413-21. PubMed ID: 10819535 [TBL] [Abstract][Full Text] [Related]
52. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways. Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326 [TBL] [Abstract][Full Text] [Related]
53. Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations. Sato K; Koyasu M; Nomura S; Sato Y; Kita M; Ashihara Y; Adachi Y; Ohno S; Iwase T; Kitagawa D; Nakashima E; Yoshida R; Miki Y; Arai M Cancer Sci; 2017 Nov; 108(11):2287-2294. PubMed ID: 28796317 [TBL] [Abstract][Full Text] [Related]
54. Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2. Eoh KJ; Kim JE; Park HS; Lee ST; Park JS; Han JW; Lee JY; Kim S; Kim SW; Kim JH; Kim YT; Nam EJ Cancer Res Treat; 2018 Jul; 50(3):917-925. PubMed ID: 29020732 [TBL] [Abstract][Full Text] [Related]
55. Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer. Ebi H; Matsuo K; Sugito N; Suzuki M; Osada H; Tajima K; Ueda R; Takahashi T Cancer Res; 2007 Dec; 67(23):11158-65. PubMed ID: 18056440 [TBL] [Abstract][Full Text] [Related]
56. Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families. Desjardins S; Belleau P; Labrie Y; Ouellette G; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; ; Durocher F Int J Cancer; 2008 Jan; 122(1):108-16. PubMed ID: 17764113 [TBL] [Abstract][Full Text] [Related]
57. Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond Samuel D; Diaz-Barbe A; Pinto A; Schlumbrecht M; George S Cells; 2022 Feb; 11(3):. PubMed ID: 35159349 [TBL] [Abstract][Full Text] [Related]